Alibaba Health Information Technology Limited (0241.HK)
HKD 3.45
(-0.29%)
HKD 3.45
(-0.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 883.47 Million CNY | 64.93% |
| 2022 | 535.65 Million CNY | 301.71% |
| 2021 | -265.55 Million CNY | -176.18% |
| 2020 | 348.58 Million CNY | 5392.86% |
| 2019 | -6.58 Million CNY | 91.96% |
| 2018 | -81.94 Million CNY | 23.39% |
| 2017 | -106.97 Million CNY | 48.48% |
| 2016 | -207.62 Million CNY | -8.36% |
| 2015 | -191.6 Million CNY | -135.91% |
| 2014 | -81.22 Million CNY | -1469.16% |
| 2013 | -5.17 Million CNY | 84.37% |
| 2012 | -33.11 Million CNY | -426.91% |
| 2011 | -6.28 Million CNY | 71.74% |
| 2010 | -22.23 Million CNY | 50.98% |
| 2009 | -45.35 Million CNY | 65.25% |
| 2008 | -130.51 Million CNY | -89.25% |
| 2007 | -68.96 Million CNY | -8.06% |
| 2006 | -63.81 Million CNY | -1082.06% |
| 2005 | 6.49 Million CNY | -75.91% |
| 2004 | 26.97 Million CNY | 1348.17% |
| 2003 | -2.16 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 FY | 883.47 Million CNY | 64.93% |
| 2023 Q4 | 437.58 Million CNY | 0.0% |
| 2023 Q2 | 445.89 Million CNY | 0.0% |
| 2022 Q4 | 373.45 Million CNY | 0.0% |
| 2022 Q2 | 162.19 Million CNY | 0.0% |
| 2022 FY | 535.65 Million CNY | 301.71% |
| 2021 Q2 | -231.77 Million CNY | 0.0% |
| 2021 FY | -265.55 Million CNY | -176.18% |
| 2021 Q4 | -33.78 Million CNY | 0.0% |
| 2020 Q4 | 65.15 Million CNY | 0.0% |
| 2020 FY | 348.58 Million CNY | 5392.86% |
| 2020 Q2 | 283.43 Million CNY | 0.0% |
| 2019 FY | -6.58 Million CNY | 91.96% |
| 2019 Q2 | -1.1 Million CNY | 0.0% |
| 2019 Q4 | -5.48 Million CNY | 0.0% |
| 2018 Q2 | -84.1 Million CNY | 0.0% |
| 2018 FY | -81.94 Million CNY | 23.39% |
| 2018 Q4 | 2.15 Million CNY | 0.0% |
| 2017 FY | -106.97 Million CNY | 48.48% |
| 2017 Q2 | -90.91 Million CNY | 0.0% |
| 2017 Q4 | -16.06 Million CNY | 0.0% |
| 2016 FY | -207.62 Million CNY | -8.36% |
| 2016 Q2 | -102.39 Million CNY | 0.0% |
| 2016 Q4 | -105.22 Million CNY | 0.0% |
| 2015 Q4 | -91.12 Million CNY | 0.0% |
| 2015 Q2 | -100.48 Million CNY | 0.0% |
| 2015 FY | -191.6 Million CNY | -135.91% |
| 2014 FY | -81.22 Million CNY | -1469.16% |
| 2014 Q4 | -54.23 Million CNY | 0.0% |
| 2014 Q2 | -26.68 Million CNY | 0.0% |
| 2013 Q3 | -1.29 Million CNY | 92.94% |
| 2013 Q1 | -8.27 Million CNY | 61.26% |
| 2013 FY | -5.17 Million CNY | 84.37% |
| 2013 Q4 | -12.8 Million CNY | -889.58% |
| 2013 Q2 | -18.32 Million CNY | -121.43% |
| 2012 Q2 | -1.57 Million CNY | 0.0% |
| 2012 FY | -33.11 Million CNY | -426.91% |
| 2012 Q4 | -21.36 Million CNY | -158.1% |
| 2012 Q3 | -8.27 Million CNY | -426.91% |
| 2012 Q1 | -1.57 Million CNY | 0.0% |
| 2011 Q2 | -5.55 Million CNY | 0.0% |
| 2011 Q3 | -1.57 Million CNY | 71.74% |
| 2011 Q4 | -1.57 Million CNY | 0.0% |
| 2011 FY | -6.28 Million CNY | 71.74% |
| 2011 Q1 | -5.55 Million CNY | 0.0% |
| 2010 Q2 | -11.33 Million CNY | 0.0% |
| 2010 FY | -22.23 Million CNY | 50.98% |
| 2010 Q4 | -5.55 Million CNY | 0.0% |
| 2010 Q1 | -11.33 Million CNY | 0.0% |
| 2010 Q3 | -5.55 Million CNY | 50.98% |
| 2009 Q2 | -32.62 Million CNY | 0.0% |
| 2009 FY | -45.35 Million CNY | 65.25% |
| 2009 Q1 | -32.62 Million CNY | 0.0% |
| 2009 Q3 | -11.33 Million CNY | 65.25% |
| 2009 Q4 | -11.33 Million CNY | 0.0% |
| 2008 Q4 | -32.62 Million CNY | 0.0% |
| 2008 Q2 | -17.24 Million CNY | 0.0% |
| 2008 Q1 | -17.24 Million CNY | 0.0% |
| 2008 FY | -130.51 Million CNY | -89.25% |
| 2008 Q3 | -32.62 Million CNY | -89.25% |
| 2007 Q1 | -15.95 Million CNY | 0.0% |
| 2007 Q3 | -17.24 Million CNY | -8.06% |
| 2007 Q4 | -17.24 Million CNY | 0.0% |
| 2007 Q2 | -15.95 Million CNY | 0.0% |
| 2007 FY | -68.96 Million CNY | -8.06% |
| 2006 Q2 | 1.62 Million CNY | 0.0% |
| 2006 Q3 | -15.95 Million CNY | -1082.06% |
| 2006 Q4 | -15.95 Million CNY | 0.0% |
| 2006 FY | -63.81 Million CNY | -1082.06% |
| 2006 Q1 | 1.62 Million CNY | 0.0% |
| 2005 Q2 | 6.74 Million CNY | 0.0% |
| 2005 FY | 6.49 Million CNY | -75.91% |
| 2005 Q4 | 1.62 Million CNY | 0.0% |
| 2005 Q1 | 6.74 Million CNY | 0.0% |
| 2005 Q3 | 1.62 Million CNY | -75.91% |
| 2004 Q1 | -540.33 Thousand CNY | 0.0% |
| 2004 Q3 | 6.74 Million CNY | 1348.17% |
| 2004 FY | 26.97 Million CNY | 1348.17% |
| 2004 Q2 | -540.33 Thousand CNY | 0.0% |
| 2004 Q4 | 6.74 Million CNY | 0.0% |
| 2003 Q3 | -540.33 Thousand CNY | 0.0% |
| 2003 FY | -2.16 Million CNY | 0.0% |
| 2003 Q4 | -540.33 Thousand CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| China Healthwise Holdings Limited | -134.55 Million HKD | 756.577% |
| Tycoon Group Holdings Limited | 297.31 Million HKD | -197.148% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 540.39 Million HKD | -63.488% |